Provided by Tiger Trade Technology Pte. Ltd.

PMGC Holdings

5.03
-0.1600-3.08%
Pre-market: 5.030.00000.00%04:45 EDT
Volume:53.82K
Turnover:281.99K
Market Cap:4.07M
PE:0.00
High:5.30
Open:5.15
Low:5.03
Close:5.19
52wk High:2,671.20
52wk Low:5.03
Shares:809.58K
Float Shares:764.19K
Volume Ratio:0.78
T/O Rate:7.04%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1,801.7300
EPS(LYR):-3,806.9050
ROE:-105.22%
ROA:-32.97%
PB:0.24
PE(LYR):0.00

Loading ...

U.S. Stocks on the MOVE-GoPro, TXNM Energy, Emergent BioSolutions

Reuters
·
Yesterday

PMGC Unit NorthStrive Biosciences Expands AI Drug Discovery Program with Yuva Biosciences

Reuters
·
Yesterday

Northstrive Biosciences - Amendment Grants Co Right of First Refusal for Exclusive License in Cardiometabolic Field

THOMSON REUTERS
·
Yesterday

Northstrive Biosciences Expands AI-Driven Drug Discovery Program with Yuva Biosciences, Advancing Four Novel AI-Discovered Compounds Toward Lead Nomination for Potential Cardiac Disease and Obesity Therapeutic Applications

THOMSON REUTERS
·
Yesterday

Northstrive Biosciences - Expansion Program Expected to Take 6 Months and Culminate in Lead Compound Nomination

THOMSON REUTERS
·
Yesterday

PMGC Plans CAD 200,000 Orbit2Orbit Share Subscription at CAD 0.8 Per Share

Reuters
·
Aug 28

PMGC terminates non-binding letter of intent to acquire Arizona company

TIPRANKS
·
Aug 26

PMGC Holdings Terminates LOI to Buy 76% Stake in Arizona Precision Machining Company

Reuters
·
Aug 26

Pmgc - Incurs no Breakup Fee or Termination Penalty for Loi Termination

THOMSON REUTERS
·
Aug 26

Pmgc Holdings Terminates Previously Announced Acquisition Loi Following Due Diligence Review; Reaffirms Disciplined M&a Strategy and Expands Investment Across Aerospace & Defense Manufacturing Portfolio

THOMSON REUTERS
·
Aug 26

PMGC Holdings Terminates Previously Announced Acquisition LOI Following Due Diligence Review; Reaffirms Disciplined M&A Strategy and Expands Investment Across Aerospace & Defense Manufacturing Portfolio

GlobeNewswire
·
Aug 26

PMGC Signs Term Sheet with Orbit2Orbit for NorthStrive Microgravity Muscle-Loss Study

Reuters
·
Aug 25

Pmgc Holdings Announces Term Sheet with Orbit2orbit for Northstrive Biosciences to Launch a Spaceflight Study of Its Myostatin and Activin a Assets, El-22 and El-32, Targeting Microgravity-Induced Muscle Loss

THOMSON REUTERS
·
Aug 25

PMGC Unit NorthStrive Biosciences Files US Patents for EL-22, EL-32 to Curb Microgravity Muscle Loss

Reuters
·
Aug 21

Northstrive Biosciences Announces the Filing of Two U.S. Patent Applications Targeting Microgravity-Induced Muscle Loss During Long-Duration Spaceflight

THOMSON REUTERS
·
Aug 21

PMGC announces 1-for-10 reverse stock split

TIPRANKS
·
Aug 19

PMGC to Execute 1-for-10 Reverse Stock Split on Aug. 21

Reuters
·
Aug 19

Pmgc - to Effect 1-for-10 Reverse Stock Split Effective August 21, 2026

THOMSON REUTERS
·
Aug 19

PMGC Q2 FY26 Net Loss Widens to $2.96 Million; Revenue Turns Positive to $1.31 Million

Reuters
·
Aug 14

Pmgc Holdings Inc. [Nasdaq: Elab] Reports Q2 2026 Results and Files Form 10-Q; Total Assets Reach $36.6 Million, up 184% from Year-End 2025 and 290% Year-over-Year, as Quarterly Revenue Nearly Doubles Sequentially

THOMSON REUTERS
·
Aug 14